Ian Taylor
Chairman of Scientific Advisory BoardDr. Ian Taylor, Ph.D., is Scientific Advisory Board Member at Atommap Corporation since April 2026. He is Scientific Advisory Board Chairman of Arvinas, Inc. from 2025. He was President of Research and Development at Arvinas, Inc. since June 17, 2024 until June 06, 2025 and was its Chairman of Scientific Advisory Board since June 17, 2024 and was its Chief Scientific Officer since March 2019 until June 17, 2024 and served as its Senior Vice President of Biology since January 2018 until April 2019. He will remain with Arvinas, Inc. until June 06, 2026. He serves as Director at EvolveImmune Therapeutics Holding Company, LLC. He serves as Director at Evolveimmune Therapeutics Inc. Dr. Taylor served Vice President, Biology at Arvinas, Inc since August 2016 until December 2017 and Vice President, Pharmacology and Translational Medicine from June 2016 to July 2016. Immediately prior to joining Arvinas, Dr. Taylor served as Senior Director, Early Development Team Leader at Pfizer Inc., a biopharmaceutical company, from February 2007 to May 2016. Dr. Taylor holds a Ph.D. in molecular biology and genetics from Harvard University and a B.A. in Biochemistry from Bowdoin College.
Positions
- Company NameArvinas, Inc.Stock CodeARVNPositionChairman of Scientific Advisory BoardColleagues
- ARAndrew R. SaikCFO & Treasurer
- BDBriggs Duncan W. MorrisonIndependent Chairman & Lead Director
- AMAngela M. CacaceChief Scientific Officer
- RTRandy TeelCEO, President & Director
- DKDavid K. LoomisVP & Chief Accounting Officer
- JBJeff BoyleVice President of Investor Relations
- EMEdward Moore KennedyIndependent Director
- LVLeslie V. NorwalkIndependent Director
